Laurel Grove Capital’s Dentsply Sirona XRAY Stock Holding History

Laurel Grove Capital’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-4,500	Closed	-$296K	–	102
2017 Q4	$296K	Sell	4,500 -1,400	-24%	-$89K	0.15%	91
2017 Q3	$353K	Hold	5,900	–	–	0.18%	88
2017 Q2	$383K	Hold	5,900	–	–	0.2%	83
2017 Q1	$368K	Hold	5,900	–	–	0.19%	84
2016 Q4	$341K	Hold	5,900	–	–	0.19%	89
2016 Q3	$351K	Buy	5,900 +900	+18%	+$55.3K	0.2%	85
2016 Q2	$310K	Hold	5,000	–	–	0.19%	89
2016 Q1	$308K	Hold	5,000	–	–	0.18%	90
2015 Q4	$304K	Hold	5,000	–	–	0.17%	89
2015 Q3	$253K	Hold	5,000	–	–	0.14%	98
2015 Q2	$258K	Hold	5,000	–	–	0.14%	96
2015 Q1	$254K	Hold	5,000	–	–	0.14%	99
2014 Q4	$266K	Sell	5,000 -600	-11%	-$30.5K	0.15%	85
2014 Q3	$255K	Hold	5,600	–	–	0.14%	85
2014 Q2	$265K	Sell	5,600 -800	-13%	-$37.2K	0.15%	82
2014 Q1	$295K	Sell	6,400 -1,000	-14%	-$46.3K	0.18%	83
2013 Q4	$359K	Hold	7,400	–	–	0.21%	80
2013 Q3	$321K	Hold	7,400	–	–	0.21%	78
2013 Q2	$303K	Buy	+7,400	New	+$309K	0.22%	83

Other funds holding XRAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Laurel Grove Capital's XRAY Position: Q1 2018 in Review

Laurel Grove Capital sold out of Dentsply Sirona (XRAY) in Q1 2018, closing a stake of 4,500 shares — an estimated $296K sold.

Laurel Grove Capital first reported a position in XRAY in Q2 2013 and held it in 19 quarters. The position peaked at $383K in Q2 2017. 566 funds tracked by Wall St. Rank hold XRAY as of Q1 2018.

Laurel Grove Capital reported no remaining Dentsply Sirona position as of Q1 2018 after selling out during the quarter.
Laurel Grove Capital sold 4,500 Dentsply Sirona shares in Q1 2018, an estimated $296K.
Laurel Grove Capital first reported a position in Dentsply Sirona in Q2 2013 and held it in 19 quarters.
Laurel Grove Capital's Dentsply Sirona position peaked at $383K in Q2 2017.
566 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2018.

Based on Laurel Grove Capital's 13F filing for Q1 2018, filed 11 Apr 2018.